Cargando…

Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS

Polycystic ovary syndrome (PCOS) is a disorder with a symptomatic manifestation of an array of metabolic and endocrine impairments. PCOS has a relatively high prevalence rate among young women of reproductive age and is a risk factor for some severe metabolic diseases such as T2DM, insulin insensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Rashid, Saeedi, Nizar H., Jalal, Mohammed M., Altayar, Malik A., Barnawi, Jameel, Hamadi, Abdullah, Tayeb, Faris J., Alshammari, Sanad E., Mtiraoui, Nabil, M. Ali, Mohammed Eltigani, Abuduhier, Faisel M., Ullah, Mohammad Fahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030665/
https://www.ncbi.nlm.nih.gov/pubmed/35455702
http://dx.doi.org/10.3390/jpm12040586
_version_ 1784692197519523840
author Mir, Rashid
Saeedi, Nizar H.
Jalal, Mohammed M.
Altayar, Malik A.
Barnawi, Jameel
Hamadi, Abdullah
Tayeb, Faris J.
Alshammari, Sanad E.
Mtiraoui, Nabil
M. Ali, Mohammed Eltigani
Abuduhier, Faisel M.
Ullah, Mohammad Fahad
author_facet Mir, Rashid
Saeedi, Nizar H.
Jalal, Mohammed M.
Altayar, Malik A.
Barnawi, Jameel
Hamadi, Abdullah
Tayeb, Faris J.
Alshammari, Sanad E.
Mtiraoui, Nabil
M. Ali, Mohammed Eltigani
Abuduhier, Faisel M.
Ullah, Mohammad Fahad
author_sort Mir, Rashid
collection PubMed
description Polycystic ovary syndrome (PCOS) is a disorder with a symptomatic manifestation of an array of metabolic and endocrine impairments. PCOS has a relatively high prevalence rate among young women of reproductive age and is a risk factor for some severe metabolic diseases such as T2DM, insulin insensitivity, and obesity, while the most dominant endocrine malfunction is an excess of testosterone showing hyperandrogenism and hirsutism. MicroRNAs have been implicated as mediators of metabolic diseases including obesity and insulin resistance, as these can regulate multiple cellular pathways such as insulin signaling and adipogenesis. Genome-wide association studies during the last few years have also linked the Krüpple-like family of transcription factors such as KLF14, which contribute in mechanisms of mammalian gene regulation, with certain altered metabolic traits and risk of atherosclerosis and type-2 DM. This study has characterized the biochemical and endocrine parameters in PCOS patients with a comprehensive serum profiling in comparison to healthy controls and further examined the influence of allelic variations for miRNAs 27a (rs895819 A > G), 196a2 (rs11614913 C > T), 423 (rs6505162C > A), and transcription factor KLF14 (rs972283 A > G) gene polymorphism on the risk and susceptibility to PCOS. The experimental protocol included amplification refractory mutation-specific (ARMS)-PCR to detect and determine the presence of these polymorphic variants in the study subjects. The results in this case–control study showed that most of the serum biomarkers, both biochemical and endocrine, that were analyzed in the study demonstrated statistically significant alterations in PCOS patients, including lipids (LDL, HDL, cholesterol), T2DM markers (fasting glucose, free insulin, HOMA-IR), and hormones (FSH, LH, testosterone, and progesterone). The distribution of Krüppel-like factor 14 rs972283 G > A, miR-27a rs895819 A > G, and miR-196a-2 rs11614913 C > T genotypes analyzed within PCOS patients and healthy controls in the considered population was significant (p < 0.05), except for miR-423 rs6505162 C > A genotypes (p > 0.05). The study found that in the codominant model, KLF14-AA was strongly associated with greater PCOS susceptibility (OR 2.35, 95% CI = 1.128 to 4.893, p < 0.022), miR-27a-GA was linked to an enhanced PCOS susceptibility (OR 2.06, 95% CI = 1.165 to 3.650, p < 0.012), and miR-196a-CT was associated with higher PCOS susceptibility (OR 2.06, 95% CI = 1.191 to 3.58, p < 0.009). Moreover, allele A of KLF-14 and allele T of miR-196a2 were strongly associated with PCOS susceptibility in the considered population.
format Online
Article
Text
id pubmed-9030665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90306652022-04-23 Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS Mir, Rashid Saeedi, Nizar H. Jalal, Mohammed M. Altayar, Malik A. Barnawi, Jameel Hamadi, Abdullah Tayeb, Faris J. Alshammari, Sanad E. Mtiraoui, Nabil M. Ali, Mohammed Eltigani Abuduhier, Faisel M. Ullah, Mohammad Fahad J Pers Med Article Polycystic ovary syndrome (PCOS) is a disorder with a symptomatic manifestation of an array of metabolic and endocrine impairments. PCOS has a relatively high prevalence rate among young women of reproductive age and is a risk factor for some severe metabolic diseases such as T2DM, insulin insensitivity, and obesity, while the most dominant endocrine malfunction is an excess of testosterone showing hyperandrogenism and hirsutism. MicroRNAs have been implicated as mediators of metabolic diseases including obesity and insulin resistance, as these can regulate multiple cellular pathways such as insulin signaling and adipogenesis. Genome-wide association studies during the last few years have also linked the Krüpple-like family of transcription factors such as KLF14, which contribute in mechanisms of mammalian gene regulation, with certain altered metabolic traits and risk of atherosclerosis and type-2 DM. This study has characterized the biochemical and endocrine parameters in PCOS patients with a comprehensive serum profiling in comparison to healthy controls and further examined the influence of allelic variations for miRNAs 27a (rs895819 A > G), 196a2 (rs11614913 C > T), 423 (rs6505162C > A), and transcription factor KLF14 (rs972283 A > G) gene polymorphism on the risk and susceptibility to PCOS. The experimental protocol included amplification refractory mutation-specific (ARMS)-PCR to detect and determine the presence of these polymorphic variants in the study subjects. The results in this case–control study showed that most of the serum biomarkers, both biochemical and endocrine, that were analyzed in the study demonstrated statistically significant alterations in PCOS patients, including lipids (LDL, HDL, cholesterol), T2DM markers (fasting glucose, free insulin, HOMA-IR), and hormones (FSH, LH, testosterone, and progesterone). The distribution of Krüppel-like factor 14 rs972283 G > A, miR-27a rs895819 A > G, and miR-196a-2 rs11614913 C > T genotypes analyzed within PCOS patients and healthy controls in the considered population was significant (p < 0.05), except for miR-423 rs6505162 C > A genotypes (p > 0.05). The study found that in the codominant model, KLF14-AA was strongly associated with greater PCOS susceptibility (OR 2.35, 95% CI = 1.128 to 4.893, p < 0.022), miR-27a-GA was linked to an enhanced PCOS susceptibility (OR 2.06, 95% CI = 1.165 to 3.650, p < 0.012), and miR-196a-CT was associated with higher PCOS susceptibility (OR 2.06, 95% CI = 1.191 to 3.58, p < 0.009). Moreover, allele A of KLF-14 and allele T of miR-196a2 were strongly associated with PCOS susceptibility in the considered population. MDPI 2022-04-06 /pmc/articles/PMC9030665/ /pubmed/35455702 http://dx.doi.org/10.3390/jpm12040586 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mir, Rashid
Saeedi, Nizar H.
Jalal, Mohammed M.
Altayar, Malik A.
Barnawi, Jameel
Hamadi, Abdullah
Tayeb, Faris J.
Alshammari, Sanad E.
Mtiraoui, Nabil
M. Ali, Mohammed Eltigani
Abuduhier, Faisel M.
Ullah, Mohammad Fahad
Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS
title Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS
title_full Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS
title_fullStr Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS
title_full_unstemmed Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS
title_short Clinical Implications of Krüpple-like Transcription Factor KLF-14 and Certain Micro-RNA (miR-27a, miR-196a2, miR-423) Gene Variations as a Risk Factor in the Genetic Predisposition to PCOS
title_sort clinical implications of krüpple-like transcription factor klf-14 and certain micro-rna (mir-27a, mir-196a2, mir-423) gene variations as a risk factor in the genetic predisposition to pcos
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030665/
https://www.ncbi.nlm.nih.gov/pubmed/35455702
http://dx.doi.org/10.3390/jpm12040586
work_keys_str_mv AT mirrashid clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT saeedinizarh clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT jalalmohammedm clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT altayarmalika clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT barnawijameel clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT hamadiabdullah clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT tayebfarisj clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT alshammarisanade clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT mtiraouinabil clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT malimohammedeltigani clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT abuduhierfaiselm clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos
AT ullahmohammadfahad clinicalimplicationsofkruppleliketranscriptionfactorklf14andcertainmicrornamir27amir196a2mir423genevariationsasariskfactorinthegeneticpredispositiontopcos